James P. Allison Institute
As the oncology world focuses its attention on the American Society of Clinical Oncology Annual Meeting, MD Anderson’s experts are sharing their pacesetting research that will change the clinic. From cutting-edge immunotherapies and targeted therapies to advanced surgical and radiation therapy techniques, our experts are leading the way to end cancer.
Below are highlights from our presentations, details about onsite networking opportunities with our experts and information on open trainee and faculty positions at MD Anderson.
Researchers explore new possibilities for ovarian cancer treatment
When ovarian cancer recurs, it can be hard to treat. Yunfei Wen, Ph.D., and Vahid Afshar-Kharghan, M.D., are working to change that.
New approaches to managing familial adenomatous polyposis (FAP)
Familial adenomatous polyposis leads to the growth of hundreds of polyps in the gastrointestinal tract and a 100% likelihood of a colorectal cancer diagnosis. Eduardo Vilar-Sanchez, M.D., Ph.D., shares insights on current approaches to addressing the risk, as well as the latest research.
How interventional radiology is used to manage cancer-related bone pain
When cancer spreads to the bone, patients may experience severe pain. Now, interventional radiology approaches are offering patients quick and lasting relief when traditional methods of treatment and pain management aren’t options.
Meet the Experts
Visit booth 6122 to ask a question, learn about training and career opportunities and continue the conversation on key presentations with our experts.
Saturday, June 4
Sunday, June 5
James P. Allison Institute
The James P. Allison Institute is dedicated to advancing exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and unlock the full potential of science and medicine for human health. The institute builds upon the legacy of its namesake, James P. Allison, Ph.D., who was awarded the 2018 Nobel Prize in Physiology or Medicine for his fundamental discoveries in T cell biology and his invention of ipilimumab, the first immune checkpoint inhibitor to treat cancer.
Meet Dr. James Allison, Dr. Padmanee Sharma and Dr. Raghu Kalluri at the AACR annual meeting on Monday, June 6 from 2-3 p.m. at booth 6122.
Education and Training at MD Anderson
MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to graduate medical education opportunities.
Moon Shots Program
MD Anderson’s Moon Shots Program® aims to rapidly and dramatically improve cancer survival rates and reduce suffering through early detection, research and new treatments.Learn more